{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:45:53Z","timestamp":1794559553584,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fragile-X syndrome (FXS) is characterized by neurological and psychiatric problems symptomatic of cortical hyperexcitability. Recent animal studies identified deficient \u03b3-aminobutyricacid (GABA) inhibition as a key mechanism for hyperexcitability in FXS, but the GABA system remains largely unexplored in humans with the disorder. The primary objective of this study was to assess GABA-mediated inhibition and its relationship with hyperexcitability in patients with FXS. Transcranial magnetic stimulation (TMS) was used to assess cortical and corticospinal inhibitory and excitatory mechanisms in 18 patients with a molecular diagnosis of FXS and 18 healthy controls. GABA-mediated inhibition was measured with short-interval intracortical inhibition (GABA\n                    <jats:sub>A<\/jats:sub>\n                    ), long-interval intracortical inhibition (GABA\n                    <jats:sub>B<\/jats:sub>\n                    ), and the corticospinal silent period (GABA\n                    <jats:sub>A+B<\/jats:sub>\n                    ). Net intracortical facilitation involving glutamate was assessed with intracortical facilitation, and corticospinal excitability was measured with the resting motor threshold. Results showed that FXS patients had significantly reduced short-interval intracortical inhibition, increased long-interval intracortical inhibition, and increased intracortical facilitation compared to healthy controls. In the FXS group, reduced short-interval intracortical inhibition was associated with heightened intracortical facilitation. Taken together, these results suggest that reduced GABA\n                    <jats:sub>A<\/jats:sub>\n                    inhibition is a plausible mechanism underlying cortical hyperexcitability in patients with FXS. These findings closely match those observed in animal models, supporting the translational validity of these markers for clinical research.\n                  <\/jats:p>","DOI":"10.1038\/s41398-019-0650-z","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T09:03:23Z","timestamp":1574240603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Florence","family":"Morin-Parent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Champigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1126\/science.aas9963","volume":"361","author":"EJ Greenblatt","year":"2018","unstructured":"Greenblatt, E. J. & Spradling, A. C. Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins. Science 361, 709\u2013712 (2018).","journal-title":"Science"},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","volume":"86","author":"S Braat","year":"2015","unstructured":"Braat, S. & Kooy, R. F. The GABA-A receptor as a therapeutic target for neurodevelopmental disorders. Neuron 86, 1119\u20131130 (2015).","journal-title":"Neuron"},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","volume":"87","author":"A Contractor","year":"2015","unstructured":"Contractor, A., Klyachko, V. A. & Portera-Cailliau, C. Altered neuronal and circuit excitability in fragile X syndrome. Neuron 87, 699\u2013715 (2015).","journal-title":"Neuron"},{"key":"650_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0987-7053(05)80074-7","volume":"24","author":"R Ferri","year":"1994","unstructured":"Ferri, R. et al. BIT-mapped somatosensory evoked potentials in the fragile X syndrome. Clin. Neurophysiol. 24, 413\u2013426 (1994).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijdevneu.2014.05.003","volume":"36","author":"IS Knoth","year":"2014","unstructured":"Knoth, I. S., Vannasing, P., Major, P., Michaud, J. L. & Lippe, S. Alterations of visual and auditory evoked potentials in fragile X syndrome. Int J. Dev. Neurosci. 36, 90\u201397 (2014).","journal-title":"Int J. Dev. Neurosci."},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1038\/tp.2016.48","volume":"6","author":"LE Ethridge","year":"2016","unstructured":"Ethridge, L. E. et al. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl. Psychiatry 6, e787\u20138 (2016).","journal-title":"Transl. Psychiatry"},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.clinph.2011.11.039","volume":"123","author":"MJW Van der Molen","year":"2012","unstructured":"Van der Molen, M. J. W. et al. Auditory change detection in fragile X syndrome males: a brain potential study. Clin. Neurophysiol. 123, 1309\u20131318 (2012).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1152\/jn.90752.2008","volume":"100","author":"JR Gibson","year":"2008","unstructured":"Gibson, J. R., Bartley, A. F., Hays, S. A. & Huber, K. M. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J. Neurophysiol. 100, 2615\u20132626 (2008).","journal-title":"J. Neurophysiol."},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1523\/JNEUROSCI.2310-16.2017","volume":"37","author":"E Garcia-Pino","year":"2017","unstructured":"Garcia-Pino, E., Gessele, N. & Koch, U. Enhanced excitatory connectivity and disturbed sound processing in the auditory brainstem of fragile X mice. J. Neurosci. 37, 7403\u20137419 (2017).","journal-title":"J. Neurosci."},{"key":"650_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","volume":"87","author":"SB Nelson","year":"2015","unstructured":"Nelson, S. B. & Valakh, V. Excitatory\/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 87, 684\u2013698 (2015).","journal-title":"Neuron"},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","volume":"27","author":"MF Bear","year":"2004","unstructured":"Bear, M. F., Huber, K. M. & Warren, S. T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370\u2013377 (2004).","journal-title":"Trends Neurosci."},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2018.08.008","volume":"119","author":"PR Westmark","year":"2018","unstructured":"Westmark, P. R., Dekundy, A., Gravius, A., Danysz, W. & Westmark, C. J. Rescue of Fmr1KO phenotypes with mGluR5 inhibitors MRZ-8456 versus AFQ-056. Neurobiol. Dis. 119, 190\u2013198 (2018).","journal-title":"Neurobiol. Dis."},{"key":"650_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G D\u00f6len","year":"2007","unstructured":"D\u00f6len, G. et al. Correction of fragile X syndrome in mice. Neuron 56, 955\u2013962 (2007).","journal-title":"Neuron"},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-015-9134-5","volume":"8","author":"DB Bailey","year":"2016","unstructured":"Bailey, D. B. et al. Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study. J. Neurodev. Disord. 8, 1\u201310 (2016).","journal-title":"J. Neurodev. Disord."},{"key":"650_CR15","doi-asserted-by":"publisher","first-page":"321ra5","DOI":"10.1126\/scitranslmed.aab4109","volume":"8","author":"E Berry-Kravis","year":"2016","unstructured":"Berry-Kravis, E. et al. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci. Transl. Med 8, 321ra5 (2016).","journal-title":"Sci. Transl. Med"},{"key":"650_CR16","doi-asserted-by":"publisher","unstructured":"Moskalyuk A., Kooy F. R., Giugliano M. Single-cell and neuronal network alterations in an in vitro model of Fragile X syndrome. Cereb. Cortex 2019, https:\/\/doi.org\/10.1093\/cercor\/bhz068 (2019).","DOI":"10.1093\/cercor\/bhz068"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cub.2017.02.065","volume":"27","author":"LM Franco","year":"2017","unstructured":"Franco, L. M., Okray, Z., Linneweber, G. A., Hassan, B. A. & Yaksi, E. Reduced lateral inhibition impairs olfactory computations and behaviors in a drosophila model of fragile X syndrome. Curr. Biol. 27, 1111\u20131123 (2017).","journal-title":"Curr. Biol."},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41593-018-0231-0","volume":"21","author":"A Goel","year":"2018","unstructured":"Goel, A. et al. Impaired perceptual learning in a mouse model of fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. Nat. Neurosci. 21, 1404\u20131411 (2018).","journal-title":"Nat. Neurosci."},{"key":"650_CR19","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1074\/jbc.M116.772541","volume":"292","author":"JY Kang","year":"2017","unstructured":"Kang, J. Y. et al. Deficits in the activity of presynaptic \u03b3-Aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome. J. Biol. Chem. 292, 6621\u20136632 (2017).","journal-title":"J. Biol. Chem."},{"key":"650_CR20","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1113\/JP271190","volume":"593","author":"S Wahlstrom-Helgren","year":"2015","unstructured":"Wahlstrom-Helgren, S. & Klyachko, V. A. GABA-B receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome. J. Physiol. 593, 5009\u20135024 (2015).","journal-title":"J. Physiol."},{"key":"650_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","volume":"1253","author":"C D\u2019Hulst","year":"2009","unstructured":"D\u2019Hulst, C. et al. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS). Brain Res. 1253, 176\u2013183 (2009).","journal-title":"Brain Res."},{"key":"650_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11689-016-9181-6","volume":"9","author":"E Berry-Kravis","year":"2017","unstructured":"Berry-Kravis, E. et al. Arbaclofen in fragile X syndrome: results of phase 3 trials. J. Neurodev. Disord. 9, 3 (2017).","journal-title":"J. Neurodev. Disord."},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","volume":"4","author":"E Berry-Kravis","year":"2012","unstructured":"Berry-Kravis, E. et al. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci. Transl. Med 4, 152ra127 (2012).","journal-title":"Sci. Transl. Med"},{"key":"650_CR24","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1212\/WNL.0000000000003868","volume":"88","author":"WM Stern","year":"2017","unstructured":"Stern, W. M., Sander, J. W., Rothwell, J. C. & Sisodiya, S. M. Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome. Neurology 88, 1659\u20131665 (2017).","journal-title":"Neurology"},{"key":"650_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31825dcf71","volume":"79","author":"J Reis","year":"2012","unstructured":"Reis, J. et al. GABAB-ergic motor cortex dysfunction in SSADH deficiency. Neurology 79, 47\u201354 (2012).","journal-title":"Neurology"},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamapsychiatry.2015.3127","volume":"73","author":"JA Camprodon","year":"2016","unstructured":"Camprodon, J. A. & Pascual-Leone, A. Multimodal applications of transcranial magnetic stimulation for circuit-based psychiatry. JAMA Psychiatry 73, 407\u2013408 (2016).","journal-title":"JAMA Psychiatry"},{"key":"650_CR27","doi-asserted-by":"crossref","unstructured":"Murphy, S. C., Palmer, L. M., Nyffeler, T., M\u00fcri, R. M. & Larkum, M. E. Transcranial magnetic stimulation (TMS) inhibits cortical dendrites. Elife 5, 735 (2016).","DOI":"10.7554\/eLife.13598"},{"key":"650_CR28","first-page":"1918","volume":"6","author":"B Li","year":"2017","unstructured":"Li, B. et al. Lifting the veil on the dynamics of neuronal activities evoked by transcranial magnetic stimulation. Elife 6, 1918 (2017).","journal-title":"Elife"},{"key":"650_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinph.2014.08.028","volume":"126","author":"U Ziemann","year":"2015","unstructured":"Ziemann, U. et al. TMS and drugs revisited 2014. Clin. Neurophysiol. 126, 1\u201322 (2015).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR30","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.clinph.2016.06.025","volume":"127","author":"AA de Goede","year":"2016","unstructured":"de Goede, A. A., Braack ter, E. M. & van Putten, M. J. A. M. Single and paired pulse transcranial magnetic stimulation in drug naive epilepsy. Clin. Neurophysiol. 127, 3140\u20133155 (2016).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.clinph.2007.10.014","volume":"119","author":"R Chen","year":"2008","unstructured":"Chen, R. et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin. Neurophysiol. 119, 504\u2013532 (2008).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR32","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","volume":"120","author":"S Rossi","year":"2009","unstructured":"Rossi, S. et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120, 2008\u20132039 (2009).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR33","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.clinph.2012.01.010","volume":"123","author":"S Groppa","year":"2012","unstructured":"Groppa, S. et al. A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee. Clin. Neurophysiol. 123, 858\u2013882 (2012).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR34","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.clinph.2008.05.031","volume":"119","author":"SH Peurala","year":"2008","unstructured":"Peurala, S. H., M\u00fcller-Dahlhaus, J. F., Arai, N. & Ziemann, U. Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF). Clin. Neurophysiol. 119, 2291\u20132297 (2008).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/hbm.21481","volume":"34","author":"JF Lepage","year":"2011","unstructured":"Lepage, J. F. et al. Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy. Hum. Brain Mapp. 34, 936\u2013944 (2011).","journal-title":"Hum. Brain Mapp."},{"key":"650_CR36","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1016\/j.clinph.2016.04.001","volume":"127","author":"Chang","year":"2016","unstructured":"Chang et al. Optimal number of pulses as outcome measures of neuronavigated transcranial magnetic stimulation. Clin. Neurophysiol. 127, 2892\u20132897 (2016).","journal-title":"Clin. Neurophysiol."},{"key":"650_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.neuron.2018.12.026","volume":"101","author":"MW Antoine","year":"2019","unstructured":"Antoine, M. W., Langberg, T., Schnepel, P. & Feldman, D. E. Increased excitation-inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models. Neuron 101, 648\u2013661 (2019).","journal-title":"Neuron"},{"key":"650_CR38","doi-asserted-by":"crossref","unstructured":"D\u2019Hulst C. et al. Positron emission tomography (PET) quantification of GABAA receptors in the brain of fragile X patients. PLoS ONE 10, e0131486\u201312 (2015).","DOI":"10.1371\/journal.pone.0131486"},{"key":"650_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2010","unstructured":"Rudy, B., Fishell, G., Lee, S. & Hjerling-Leffler, J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev. Neurobiol. 71, 45\u201361 (2010).","journal-title":"Dev. Neurobiol."},{"key":"650_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0006-8993(94)91060-X","volume":"649","author":"Y Kubota","year":"1994","unstructured":"Kubota, Y., Hattori, R. & Yui, Y. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649, 159\u2013173 (1994).","journal-title":"Brain Res."},{"key":"650_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.062","volume":"412","author":"L Selby","year":"2007","unstructured":"Selby, L., Zhang, C. & Sun, Q.-Q. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412, 227\u2013232 (2007).","journal-title":"Neurosci. Lett."},{"key":"650_CR42","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1523\/JNEUROSCI.1379-10.2011","volume":"31","author":"A Benali","year":"2011","unstructured":"Benali, A. et al. Theta-burst transcranial magnetic stimulation alters cortical inhibition. J. Neurosci. 31, 1193\u20131203 (2011).","journal-title":"J. Neurosci."},{"key":"650_CR43","doi-asserted-by":"publisher","first-page":"13553","DOI":"10.1073\/pnas.1405508111","volume":"111","author":"V Kozyrev","year":"2014","unstructured":"Kozyrev, V., Eysel, U. T. & Jancke, D. Voltage-sensitive dye imaging of transcranial magnetic stimulation-induced intracortical dynamics. Proc. Natl Acad. Sci. USA 111, 13553\u201313558 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"650_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1022606200636","volume":"15","author":"M Castren","year":"2003","unstructured":"Castren, M., Paakkonen, A., Tarkka, I. M., Ryynanen, M. & Partanen, J. Augmentation of auditory N1 in children with fragile X syndrome. Brain Topogr. 15, 165\u2013171 (2003).","journal-title":"Brain Topogr."},{"key":"650_CR45","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1212\/WNL.51.5.1320","volume":"51","author":"U Ziemann","year":"1998","unstructured":"Ziemann, U., Chen, R., Cohen, L. G. & Hallett, M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51, 1320\u20131324 (1998).","journal-title":"Neurology"},{"key":"650_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1113\/jphysiol.2007.144824","volume":"586","author":"J Reis","year":"2008","unstructured":"Reis, J. et al. Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control. J. Physiol. 586, 325\u2013351 (2008).","journal-title":"J. Physiol."},{"key":"650_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1469-7793.1998.607bn.x","volume":"509","author":"R Hanajima","year":"1998","unstructured":"Hanajima, R. et al. Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J. Physiol. 509, 607\u2013618 (1998).","journal-title":"J. Physiol."},{"key":"650_CR48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1113\/jphysiol.1996.sp021734","volume":"496","author":"U Ziemann","year":"1996","unstructured":"Ziemann, U., Rothwell, J. C. & Ridding, M. C. Interaction between intracortical inhibition and facilitation in human motor cortex. J. Physiol. 496, 873\u2013881 (1996).","journal-title":"J. Physiol."},{"key":"650_CR49","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1113\/jphysiol.2003.059808","volume":"557","author":"ZJ Daskalakis","year":"2004","unstructured":"Daskalakis, Z. J. et al. Exploring the connectivity between the cerebellum and motor cortex in humans. J. Physiol. 557, 689\u2013700 (2004).","journal-title":"J. Physiol."},{"key":"650_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00221-006-0365-2","volume":"173","author":"MN McDonnell","year":"2006","unstructured":"McDonnell, M. N., Orekhov, Y. & Ziemann, U. The role of GABAB receptors in intracortical inhibition in the human motor cortex. Exp. Brain Res 173, 86\u201393 (2006).","journal-title":"Exp. Brain Res"},{"key":"650_CR51","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-7793.1999.0591t.x","volume":"517","author":"KJ Werhahn","year":"1999","unstructured":"Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R. & Classen, J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J. Physiol. 517, 591\u2013597 (1999).","journal-title":"J. Physiol."},{"key":"650_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2004.06.009","volume":"1028","author":"M Pierantozzi","year":"2004","unstructured":"Pierantozzi, M. et al. Effect of Vigabatrin on motor responses to transcranial magnetic stimulation. Brain Res 1028, 1\u20138 (2004).","journal-title":"Brain Res"},{"key":"650_CR53","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1523\/JNEUROSCI.4989-12.2013","volume":"33","author":"WM Connelly","year":"2013","unstructured":"Connelly, W. M. et al. GABAB receptors regulate extrasynaptic GABAA receptors. J. Neurosci. 33, 3780\u20133785 (2013).","journal-title":"J. Neurosci."},{"key":"650_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nn.2563","volume":"13","author":"MR Brown","year":"2010","unstructured":"Brown, M. R. et al. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Nat. Neurosci. 13, 819\u2013821 (2010).","journal-title":"Nat. Neurosci."},{"key":"650_CR55","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1016\/j.celrep.2016.08.046","volume":"16","author":"P-Y Deng","year":"2016","unstructured":"Deng, P.-Y. & Klyachko, V. A. Increased persistent sodium current causes neuronal hyperexcitability in the entorhinal cortex of Fmr1 knockout mice. Cell Rep. 16, 3157\u20133166 (2016).","journal-title":"Cell Rep."},{"key":"650_CR56","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1113\/JP274258","volume":"595","author":"BN Routh","year":"2017","unstructured":"Routh, B. N. et al. Increased transient Na+ conductance and action potential output in layer 2\/3 prefrontal cortex neurons of the fmr1\u2212\/ymouse. J. Physiol. 595, 4431\u20134448 (2017).","journal-title":"J. Physiol."},{"key":"650_CR57","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/cercor\/bhm100","volume":"18","author":"M Fedi","year":"2008","unstructured":"Fedi, M. et al. Intracortical hyperexcitability in humans with a GABAA receptor mutation. Cereb. Cortex 18, 664\u2013669 (2008).","journal-title":"Cereb. Cortex"},{"key":"650_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1152\/jn.00510.2012","volume":"109","author":"MG Stokes","year":"2013","unstructured":"Stokes, M. G. et al. Biophysical determinants of transcranial magnetic stimulation: effects of excitability and depth of targeted area. J. Neurophysiol. 109, 437\u2013444 (2013).","journal-title":"J. Neurophysiol."},{"key":"650_CR59","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.neuroimage.2013.07.033","volume":"83","author":"J List","year":"2013","unstructured":"List, J. et al. Relationship between excitability, plasticity and thickness of the motor cortex in older adults. NeuroImage 83, 809\u2013816 (2013).","journal-title":"NeuroImage"},{"key":"650_CR60","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.neuroimage.2008.01.019","volume":"40","author":"S Kl\u00f6ppel","year":"2008","unstructured":"Kl\u00f6ppel, S. et al. The cortical motor threshold reflects microstructural properties of cerebral white matter. NeuroImage 40, 1782\u20131791 (2008).","journal-title":"NeuroImage"},{"key":"650_CR61","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.neuroimage.2006.05.059","volume":"32","author":"M Fedi","year":"2006","unstructured":"Fedi, M. et al. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. NeuroImage 32, 995\u20131000 (2006).","journal-title":"NeuroImage"},{"key":"650_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","volume":"1121","author":"C D\u2019Hulst","year":"2006","unstructured":"D\u2019Hulst, C. et al. Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121, 238\u2013245 (2006).","journal-title":"Brain Res."},{"key":"650_CR63","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.4161\/15384101.2014.989114","volume":"14","author":"S Braat","year":"2015","unstructured":"Braat, S. et al. The GABA Areceptor is an FMRP target with therapeutic potential in fragile X syndrome. Cell Cycle 14, 2985\u20132995 (2015).","journal-title":"Cell Cycle"},{"key":"650_CR64","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/archneur.61.10.1585","volume":"61","author":"C Civardi","year":"2004","unstructured":"Civardi, C., Vicentini, R., Grugni, G. & Cantello, R. Corticospinal physiology in patients with Prader\u2013Willi syndrome: a transcranial magnetic stimulation study. Arch. Neurol. 61, 1585\u20131589 (2004).","journal-title":"Arch. Neurol."},{"key":"650_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","volume":"73","author":"PL Pearl","year":"2009","unstructured":"Pearl, P. L. et al. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 73, 423\u2013429 (2009).","journal-title":"Neurology"},{"key":"650_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuroimage.2003.10.050","volume":"22","author":"G Lucignani","year":"2004","unstructured":"Lucignani, G. et al. GABAA receptor abnormalities in Prader\u2013Willi syndrome assessed with positron emission tomography and [11C]flumazenil. NeuroImage 22, 22\u201328 (2004).","journal-title":"NeuroImage"},{"key":"650_CR67","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1542\/peds.2016-1159B","volume":"139","author":"C Riley","year":"2017","unstructured":"Riley, C., Mailick, M., Berry-Kravis, E. & Bolen, J. The future of fragile X syndrome: CDC stakeholder meeting summary. Pediatrics 139, S147\u2013S152 (2017).","journal-title":"Pediatrics"},{"key":"650_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis, E. M. et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat. Rev. Drug Disco. 17, 280\u2013299 (2018).","journal-title":"Nat. Rev. Drug Disco."},{"key":"650_CR69","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00213-013-3289-0","volume":"231","author":"S Jacquemont","year":"2013","unstructured":"Jacquemont, S. et al. The challenges of clinical trials in fragile X syndrome. Psychopharmacol. (Berl.) 231, 1237\u20131250 (2013).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"650_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neubiorev.2016.05.029","volume":"76","author":"D Sinclair","year":"2016","unstructured":"Sinclair, D., Oranje, B., Razak, K. A., Siegel, S. J. & Schmid, S. Sensory processing in autism spectrum disorders and Fragile X syndrome\u2014from the clinic to animal models. Neurosci. Biobehav Rev. 76, 235\u2013253 (2016).","journal-title":"Neurosci. Biobehav Rev."},{"key":"650_CR71","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/0269881113494105","volume":"27","author":"A Schneider","year":"2013","unstructured":"Schneider, A. et al. Electrocortical changes associated with minocycline treatment in fragile X syndrome. J. Psychopharmacol. (Oxf.) 27, 956\u2013963 (2013).","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"650_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2018.03.012","volume":"115","author":"JW Lovelace","year":"2018","unstructured":"Lovelace, J. W., Ethell, I. M., Binder, D. K. & Razak, K. A. Translation-relevant EEG phenotypes in a mouse model of fragile X syndrome. Neurobiol. Dis. 115, 39\u201348 (2018).","journal-title":"Neurobiol. Dis."},{"key":"650_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0140-1","volume":"8","author":"LE Ethridge","year":"2017","unstructured":"Ethridge, L. E. et al. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome. Mol. Autism 8, 22 (2017).","journal-title":"Mol. Autism"},{"key":"650_CR74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1152\/jn.00782.2009","volume":"103","author":"RFH Cash","year":"2010","unstructured":"Cash, R. F. H., Ziemann, U., Murray, K. & Thickbroom, G. W. Late cortical disinhibition in human motor cortex: a triple-pulse transcranial magnetic stimulation study. J. Neurophysiol. 103, 511\u2013518 (2010).","journal-title":"J. Neurophysiol."},{"key":"650_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroimage.2014.09.028","volume":"103","author":"I Premoli","year":"2014","unstructured":"Premoli, I. et al. Characterization of GABAB-receptor mediated neurotransmission in the human cortex by paired-pulse TMS\u2013EEG. NeuroImage 103, 152\u2013162 (2014).","journal-title":"NeuroImage"},{"key":"650_CR76","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/npp.2016.133","volume":"42","author":"RFH Cash","year":"2016","unstructured":"Cash, R. F. H. et al. Characterization of glutamatergic and GABAA-mediated neurotransmission in motor and dorsolateral prefrontal cortex using paired-pulse TMS&EEG. Neuropsychopharmacology 42, 502\u2013511 (2016).","journal-title":"Neuropsychopharmacology"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0650-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T10:57:02Z","timestamp":1671188222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0650-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1038\/s41398-019-0650-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"18 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"312"}}